Positive Sequence Biology has raised $6M in total funding. Latest round: Seed. Backed by Zoo Capital, New Alliance Capital, Sequoia China.
Positive Sequence Biology funding overview
Positive Sequence Biology has raised $6M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Seed announced in January 2021. The round record for Positive Sequence Biology runs through 2021; nothing later has been disclosed. Investors on record include Zoo Capital, New Alliance Capital, Sequoia China, TF Capital. 4 distinct backers are named across the disclosed rounds.
Positive Sequence Biology at a glance
Total raised
$6M
Latest round
Seed
Latest round date
January 2021
Notable investors
Zoo Capital, New Alliance Capital, Sequoia China, TF Capital
Frequently asked about Positive Sequence Biology funding
How much has Positive Sequence Biology raised?
Positive Sequence Biology has raised $6M in total disclosed funding across the rounds on record.
Who has invested in Positive Sequence Biology?
Zoo Capital, New Alliance Capital, Sequoia China, TF Capital are named among the investors backing Positive Sequence Biology.
What was the latest Positive Sequence Biology funding round?
The most recent disclosed round is a Seed, announced in January 2021.
Where is Positive Sequence Biology based?
No headquarters location is disclosed for Positive Sequence Biology.
When did Positive Sequence Biology last raise?
The last disclosed Positive Sequence Biology round closed in January 2021 at Seed.
Round data for Positive Sequence Biology is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.
Companies related to Positive Sequence Biology (33)
